In NSCLC, KRAS mutations are often accompanied by loss of the tumor suppressor STK11, which encodes the LKB1 kinase, leading to the formation of aggressive tumors characterized by perturbed nitrogen handling (9). The gene discussed is STK11; the disease is non-small cell lung carcinoma.